Literature DB >> 15355468

Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro.

C Dahl1, H J Hoffmann, H Saito, P O Schiøtz.   

Abstract

BACKGROUND: Mast cells have long been recognized as the principal cell type that initiates the inflammatory response characteristic of acute allergic type 1 reactions. Our goal has been to further characterize maturation of progenitors to mast cells.
METHODS: Mast cells were cultured from human cord blood derived CD133(+) progenitors. Mast cell function was tested using histamine release. During differentiation mast cells surface marker expression was monitored by flow cytometry.
RESULTS: CD133(+) progenitors expressed the early haematopoietic and myeloid lineage markers CD34, CD117, CD13 and CD33. Mature mast cells expressed CD117, CD13 and CD33, and expression of the high affinity immunoglobulin E receptor FcepsilonRI increased during culture. Cytokine receptors interleukin (IL)-5R, IL-3R, granulocyte-macrophage-colony stimulating factor (GM-CSF)R and IL-18R were expressed at high levels during maturation. Chemokine receptors CXCR4 and CXCR2 were highly expressed on both newly purified CD133(+) cells and mature cells.
CONCLUSION: Human mast cells can be cultured from a CD34(+)/CD117(+)/CD13(+)/CD33(+) progenitor cell population in cord blood that is tryptase and chymase negative. Developing and mature mast cells express a wide range of chemokine and cytokine receptors. We found high levels of expression of CD123, IL-5R and GM-CSF receptors, also found on eosinophils and basophils, and high levels of expression of the receptor for the inflammatory cytokine IL-18.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355468     DOI: 10.1111/j.1398-9995.2004.00606.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  18 in total

Review 1.  FIP1L1/PDGFR alpha-associated systemic mastocytosis.

Authors:  Yoshiyuki Yamada; Jose A Cancelas
Journal:  Int Arch Allergy Immunol       Date:  2010-06-04       Impact factor: 2.749

Review 2.  Gene therapy for radioprotection.

Authors:  W H Everett; D T Curiel
Journal:  Cancer Gene Ther       Date:  2015-02-27       Impact factor: 5.987

Review 3.  Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells.

Authors:  Jennine Grootens; Johanna S Ungerstedt; Gunnar Nilsson; Joakim S Dahlin
Journal:  Blood Adv       Date:  2018-09-11

Review 4.  Human eosinophils and mast cells: Birds of a feather flock together.

Authors:  Piper A Robida; Pier Giorgio Puzzovio; Hadas Pahima; Francesca Levi-Schaffer; Bruce S Bochner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

5.  IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.

Authors:  Todd M Wilson; Irina Maric; Juhi Shukla; Margaret Brown; Carlo Santos; Olga Simakova; Paneez Khoury; Michael P Fay; Alexander Kozhich; Roland Kolbeck; Dean D Metcalfe; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2011-07-16       Impact factor: 10.793

6.  Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.

Authors:  Iris M Otani; Arjun A Anilkumar; Robert O Newbury; Monica Bhagat; Lisa Y Beppu; Ranjan Dohil; David H Broide; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2013-04-25       Impact factor: 10.793

7.  KIT signaling is dispensable for human mast cell progenitor development.

Authors:  Joakim S Dahlin; Maria Ekoff; Jennine Grootens; Liza Löf; Rose-Marie Amini; Hans Hagberg; Johanna S Ungerstedt; Ulla Olsson-Strömberg; Gunnar Nilsson
Journal:  Blood       Date:  2017-08-08       Impact factor: 22.113

Review 8.  Eosinophils: Nemeses of Pulmonary Pathogens?

Authors:  Kim S LeMessurier; Amali E Samarasinghe
Journal:  Curr Allergy Asthma Rep       Date:  2019-06-19       Impact factor: 4.806

9.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

10.  Potential mechanism for recruitment and migration of CD133 positive cells to areas of vascular inflammation.

Authors:  Prerna Rastogi; Maureen C White; Alice Rickard; Jane McHowat
Journal:  Thromb Res       Date:  2008-05-20       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.